|
MedPanel Announces New Product For Early-Stage Medical Companies
Irvine, CA - March 4, 2003 -- MedPanel, Inc., pioneers of online research for the pharmaceutical, biotech and medical device industries, introduced a new product at the recent Medtech Insight Investment In Innovation conference. The new product, MedPanel's Early-Stage Discussion, is a cost effective advisory board program specifically designed for early-stage medical device and biotech companies
Kathleen Poulos, who recently joined MedPanel as Vice President of Sales, made the announcement. As the first West Coast representative for MedPanel, she brings with her more than 19 years of health care experience ranging from the clinical setting to expertise in international sales & marketing. Prior to MedPanel, Ms. Poulos specialized in clinical messaging and market development for Baxter Healthcare, Inc.
This was Ms. Poulos' first time speaking at the conference, a two-day event highlighting emerging technologies at medical device companies. MedPanel developed the product at this time because they recognize that early-stage companies have a great need for thought leader access, yet limited resources.
MedPanel's Early-Stage Discussion is designed to provide clients access to medical experts at a reasonable price. In her announcement, Poulos cited uses for the new product, including providing foundations for product development, disseminating company information, eliciting expert opinion and advice for planning long term strategy, gaining rapid feedback on time sensitive issues, and building relationships to support future growth.
"MedPanel is excited to offer a customized advisory board solution for the early-stage medical technology company. We believe solid market information provides the basis for making strategic business decisions and is a key component in the long term positioning of an organization," said Poulos.
Conventional advisory boards and the process of acquiring thought leader input could cost hundreds of thousands of dollars, money which most early-stage companies do not have. MedPanel's solution is offered at a fraction of this price.
"In offering a customized advisory board solution, MedPanel ensures that early-stage medical technology companies have access to the market knowledge they need for successful business planning," stated Scott Fredericksen, Director of Business Development for TheraCyte, Inc.
About MedPanel
Based in Cambridge Massachusetts, MedPanel provides medical market intelligence and communications via online focus groups, advisory board meetings, and quantitative surveys. Its competitive edge results from proprietary technology and access to top tier medical experts.
Contact: Erin Sheehan 617-661-8080 x29
www.MedPanel.com